Company description

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines for some of the world’s most serious diseases. AstraZeneca is one of the world's leading pharmaceutical companies. At AstraZeneca, we're proud to have a unique workplace culture that inspires innovation and collaboration. Here, employees are empowered to express diverse perspectives - and are made to feel valued, energized and rewarded for their ideas and creativity.

AstraZeneca in Diabetes
Diabetes is a growing disease and an enormous global burden that is currently projected to affect more than 592 million people by the year 2035. AstraZeneca is seeking to positively impact the lives of patients to help reduce the disease burden ant its complications.

AstraZeneca and diabetes
We’re pursuing leading, distinctive science in diabetes with the goal of developing life-changing medicines that reduce the global burden and complications of this serious disease. 
Type-2 diabetes occurs when the body builds a resistance to insulin, meaning the body is unable to regulate blood glucose levels.
There is a clinical overlap between diabetes, cardiovascular disease (CVD) and renal diseases. People with type-2 diabetes are two to three times more likely to suffer from heart attacks and strokes compared to those without diabetes, and have a greater risk of chronic kidney disease, which affects more than 30 million adults in the United States alone.
We are committed to better understanding the interconnectivity of diabetes, cardiovascular and renal diseases and taking a holistic, patient-centric approach to disease management. 

Modern state of the art product portfolio
We are pursuing high-science research and early-action treatment options to support people living with diabetes.

AstraZeneca is the first company to offer products in all three of the newest, fastest-growing classes of type 2 diabetes treatments:
· SGLT2 inhibitors
· GLP-1 receptor agonists
· DPP-4 inhibitors

Forxiga®, an SGLT2, the latest class in the arsenal of treatments for Type 2 diabetes
Forxiga (dapagliflozin) is a selective inhibitor of human sodium-glucose co-transporter 2 (SGLT2 inhibitor) indicated as monotherapy and as part of combination therapy to improve glycaemic control in adult patients with Type 2 diabetes.

Forxiga delivers effect on HbA1c reduction as well as effect on secondary endpoints as reduced blood pressure and weight loss. There is also an ongoing extensive clinical program for Forxiga (DapaCare) and the first study from this program will be presented this year. The results from these studies will have a major impact on the future of Forxiga.

Forxiga is a top priority for AstraZeneca worldwide and also for the Diabetes team in Sweden.

 

Key Account Manager Diabetes, Stockholm AstraZeneca

Great opportunity to work with a modern state-of-the-art diabetes portfolio with top potential

The position – Key Account Manager Stockholm North

Region: Stockholms län (responsible for part of the region, Stockholm north with a KAM Diabetes colleague responsible for Stockholm south)

As a Key Account Manager (KAM) for Diabetes, you will be one of 11 Key Account Managers in Sweden, part of the National Diabetes Team and play an important role in the contribution to the diabetes franchise strategy. There are two KAM Diabetes in Stockholms län (KAM Stockholm North & KAM Stockholm South) working close together in the Stockholm region.

Key Account Manager at AstraZeneca is a field based customer-facing role responsible for the sales and customers in a defined region in this case the Stockholm County Council. The Key Account manager is responsible for diabetes communication to regional payer groups, specialists within diabetes and endocrinology, primary care, health care professional groups, specialist organizations and other relevant regional stakeholder within County Council and the Healthcare community. Key Account Manager is accountable for the regional business in collaboration with a cross-functional team, consisting of brand manager, market access and medical advisor

There is also a close relationship with AstraZeneca R&D in Mölndal that is responsible for R&D in Diabetes.

We are in an exciting phase with a modern product portfolio. There are extensive ongoing clinical trial program (DapaCare) for Forxiga, that discovers other valid benefits of the treatment with Forxiga, meaning more opportunities in the future.

Role opportunities
· Working for AstraZeneca a company with a unique history, position and reputation in Sweden as well as in the Swedish healthcare
· Have the opportunity to become a key player in a highly prioritized therapeutic area, Diabetes where AstraZeneca has a top potential portfolio and valued clinical trial programme, aiming for the market lead
· Forxiga, a novel and modern state-of-the -art treatment for diabetes type 2 patients with high potential and beneficial effects in many aspects of diabetes
· Be part of a professional and dynamic team with a pleasant team culture and a close collaboration
· Working for AstraZeneca means a lot of possible options for personal- and career development
· In case you are a leadership talent, interested in developing into a future leadership position, there are opportunities within AstraZeneca
· Be close to AstraZeneca Södertälje, the Nordic headquarter meaning close access to resources and colleagues.

Required profile

Qualifications and profile
· Academic degree or equivalent, commercial or healthcare background
· Solid experience from successful pharmaceutical sales, preferable from a Primary care area, diabetes is an advantage
· Experience from Market access responsibility and working with different stake holders and functions in the County Council and Healthcare community is an advantage
· Proven track record of strategic thinking, judgment and skills
· Proven record of strong sales performance, excellent communication and education skills
· Strong social ability with a strive to contact, meet and build long lasting relations
· A true team player with social competency, trustworthiness and with a positive and constructive mindset
· Good planning skills
· High Interest and knowledge in science
· In case you are a leadership talent, interested in developing into a future leadership position, there are opportunities within AstraZeneca
· Proven track record of engaging and developing lasting relationships with a broad base of key stakeholders in complex clinical environments, e.g., mid/senior level healthcare professionals. (desirable)
· Good understanding of the ethical code and compliance requirements
· LIF certificated within Pharma Industry or valid exemption (Pharmacist, “Receptarie”, Master in Biomedicine)
· Clean Drivers Licence


Personal characteristics
· Excellent interpersonal skills
· Flexibility and proactivity
· Impactful
· Diplomatic. Ability to interact with a range of personalities
· Ambitious. Strong drive and ability to work independently
· Positive “can-do” attitude

Languages
Fluent in spoken and written Swedish, good in English.

Contact
For further information about the position, please contact Magnus Klingberg or Jenny Ringh, Recruitment consultants at PeakSearch. Apply for the position at http://www.peaksearch.se.

PeakSearch
Tel. 08-545 00 100
http://www.peaksearch.se

Magnus Klingberg, magnus.klingberg@peaksearch.se, 070-678 09 92
Jenny Ringh, jenny@peaksearch.se, 070-235 81 99